Astellas Pharma US, Inc Satellite Symposium - non-CME

Satellite Symposium 1

Wednesday 29th August 2018
17:45 - 18:45
Hall B
Capacity: 400
Speakers

Astellas Pharma US, Inc. Satellite Symposium

COMBINATION TREATMENT FOR PATIENTS WITH OAB

Agenda

StartEndSubjectSpeaker
17:4518:05IntroductionDavid R. Staskin
18:0518:35Panel DiscussionDavid R. Staskin, Peter K. Sand, & Scott A. MacDiarmid
18:3518:45Audience Questions and AnswersAll

Programme Objectives
• Review the epidemiology of overactive bladder (OAB)
• Discuss the American Urological Association (AUA) treatment guidelines for OAB and explore the unmet needs of some patient populations
• Review clinical data of a new treatment approach for OAB
• Discuss the new treatment options for patients with OAB

Please note this session is not included in main Meeting CME/CPD credit.

The views expressed in this Satellite Symposium are those of the company and speakers and not necessarily those of the International Continence Society.